Under the new guidance, only infants whose mothers test positive for hepatitis B or whose status is unknown will automatically receive the vaccine at birth.
Everest Medicines plans to deliver predictable near-term value through commercializing existing assets, forming business development partnerships, and achieving in-house research and development milestones.
The study compared the drug against bendamustine plus rituximab (BR) in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) who had not received prior treatment and did not have 17p deletions.
Through this acquisition, Philips aims to enhance the precision and efficiency of coronary interventions, ultimately benefiting both healthcare professionals and patients.
The collaboration is designed to strengthen Everest’s commercial operations in China while expanding its presence in the cardiovascular disease market.
These investments will focus primarily on companies developing breakthrough technologies in gastrointestinal (GI), urology, and respiratory care.
The new facility is designed to deliver world-class injury management and rehabilitation for athletes, helping them recover faster, regain peak performance, and prepare for national and international competitions.
The Alabama site is part of Lilly’s USD 27 billion U.S. onshoring initiative, aimed at reinforcing domestic pharmaceutical manufacturing.
YaoPharma stands to earn as much as USD1.94 billion in additional milestone payments tied to development, regulatory, and commercial achievements.
The Bendit17 microcatheter incorporates Bendit’s proprietary real-time 3D steering technology, which enables clinicians to maneuver the device more intuitively through complex vascular pathways.